Exsurgo Exsurgo combines neuroscience, engineering, and data analysis to help treat a range of neurological conditions without the use of pharmaceuticals.
You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media.
Exsurgo has created the future of chronic pain management, Axon. Boasting safe, efficacious, and drug-free treatment, Axon offers self-treatment in the home with the remote supervision of a clinician. With successful clinical trials in the United Kingdom and New Zealand proving the clinical efficacy of chronic pain treatment with electroencephalogram neurofeedback, Axon is registered with the United States Food and Drug Administration as a chronic pain treatment, and it has also obtained a CE mark in the European Union.
- FOUNDED IN: 2015
- SECTOR: HEALTHTECH
"Exsurgo is committed to changing the way patients treat their chronic pain in UAE. Axon is as effective as pharmaceuticals, but without health condition side-effects. The presence of Axon in the UAE healthcare space thus reduces strain on the healthcare industry by reducing clinic visits, and reducing the population's usage of pharmaceuticals."
Click here to see the full Future 100 list.
